Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.46B | 13.33B | 12.65B | 9.82B | 8.58B | Gross Profit |
7.33B | 7.43B | 6.98B | 4.79B | 4.14B | EBIT |
721.72M | 890.20M | 763.53M | -1.08B | -1.20B | EBITDA |
794.93M | 1.29B | 1.29B | -275.48M | -1.23B | Net Income Common Stockholders |
136.92M | 870.08M | 918.25M | -869.30M | -1.68B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.41B | 1.82B | 2.29B | 1.87B | 413.57M | Total Assets |
10.90B | 10.76B | 11.26B | 10.98B | 10.24B | Total Debt |
2.49B | 2.97B | 4.28B | 5.18B | 4.62B | Net Debt |
-2.93B | 1.16B | 1.99B | 3.31B | 4.20B | Total Liabilities |
6.13B | 6.06B | 7.36B | 8.00B | 7.38B | Stockholders Equity |
4.77B | 4.70B | 3.90B | 2.98B | 2.86B |
Cash Flow | Free Cash Flow | |||
1.09B | 974.34M | 1.34B | 98.69M | -1.20B | Operating Cash Flow |
1.24B | 1.17B | 1.47B | 159.47M | -909.21M | Investing Cash Flow |
2.90B | -239.51M | -127.79M | -109.61M | -303.36M | Financing Cash Flow |
-540.64M | -1.41B | -921.25M | 1.40B | 1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥23.12B | 38.90 | ― | ― | ― | ||
66 Neutral | ¥20.66B | 29.35 | 0.80% | 5.86% | -23.12% | ||
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% | |
60 Neutral | ¥19.75B | 144.18 | 0.43% | 1.03% | -84.27% | ||
55 Neutral | ¥19.06B | 20.23 | 0.56% | 3.24% | -11.45% | ||
54 Neutral | ¥19.76B | 18.89 | ― | 6.19% | ― | ||
50 Neutral | ¥22.19B | 34.18 | 0.62% | 13.61% | -40.79% |